Logo image
A stonemason with accelerated silicosis in the setting of tumour necrosis factor alpha inhibitor therapy
Journal article   Open access   Peer reviewed

A stonemason with accelerated silicosis in the setting of tumour necrosis factor alpha inhibitor therapy

Timothy Baird, Michael Putt and Andrew Dettrick
Respirology Case Reports, Vol.4(5), pp.1-3
2016
PMCID: PMC4970307
PMID: 27516887
pdf
Respirology Case Reports - 2016 - Baird - A stonemason with accelerated silicosis in the setting of tumour necrosis factor10.47 MBDownloadView
Published VersionCC BY V4.0 Open Access
url
https://doi.org/10.1002/rcr2.171View
Published Version

Abstract

Silicosis stonemason TNF‐alpha inhibitor
We present the case of a 26-year-old stonemason with accelerated silicosis in the setting of treatment for psoriasis with the tumour necrosis factor alpha (TNF-alpha) inhibitor adalimumab. Accelerated silicosis is an important occupational lung disease with a poor prognosis and limited treatment options [1]. Although the exact pathogenesis remains unknown, it is suggested that secretion of cytokines, including TNF-alpha, plays a central role in disease progression [1,2]. Importantly, however, TNF-alpha inhibitors, in addition to resulting in an increased risk of infection, are also now being seen to cause interstitial lung disease [3,4]. To our knowledge, this is the first documented patient to develop silicosis whilst on TNF-alpha inhibitor therapy. This case challenges the theory behind TNF-alpha's exact role in the pathogenesis of silicosis and lung fibrosis, highlights the importance of monitoring individuals with both occupational and drug exposures, and illustrates the increasing difficulties physicians face in investigating patients with pulmonary infiltrates and multiple possible aetiologies.

Details

Metrics

151 File views/ downloads
43 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Respiratory System

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image